临床特征 | LIX1低表达 | LIX1高表达 | P值 |
T分期,n(%) | <0.001 | ||
T2期 | 61 (12.4%) | 128 (26%) | |
T3期 | 178 (36.2%) | 114 (23.2%) | |
T4期 | 7 (1.4%) | 4 (0.8%) | |
N分期,n(%) | <0.001 | ||
N0期 | 163 (38.3%) | 184 (43.2%) | |
N1期 | 58 (13.6%) | 21(4.9%) | |
M分期,n(%) | 1 | ||
M0期 | 233 (50.9%) | 222 (48.5%) | |
M1期 | 2(0.4%) | 1 (0.2%) | |
Gleason score, n(%) | <0.001 | ||
6&7 | 112 (22.4%) | 181 (36.3%) | |
8&9&10 | 137(27.4%) | 69 (13.8%) | |
年龄,n(%) | 0.01 | ||
≤60 | 97 (19.4%) | 127 (25.5%) | |
>60 | 152 (30.5%) | 123 (24.6%) | |
PSA (ng/ml), n(%) | 0.042 | ||
<4 | 200 (45.2%) | 215 (48.6%) | |
≥4 | 19 (4.3%) | 8 (1.8%) |